Eva Brčáková

448 total citations
20 papers, 366 citations indexed

About

Eva Brčáková is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eva Brčáková has authored 20 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eva Brčáková's work include Drug Transport and Resistance Mechanisms (10 papers), TGF-β signaling in diseases (4 papers) and Neonatal Health and Biochemistry (3 papers). Eva Brčáková is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), TGF-β signaling in diseases (4 papers) and Neonatal Health and Biochemistry (3 papers). Eva Brčáková collaborates with scholars based in Czechia and Hungary. Eva Brčáková's co-authors include Stanislav Mičuda, Jolana Cermanová, Leoš Fuksa, František Štaud, Jaroslav Mokrý, M Hroch, Petra Hirsova, Petr Nachtigal, Jiřina Martı́nková and Tomáš Soukup and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Toxicology.

In The Last Decade

Eva Brčáková

20 papers receiving 360 citations

Peers

Eva Brčáková
Neelam Tejpal United States
A. Kivitz United States
Weinan Du United States
Roberta Sarmiento Italy
Gary L. Engelmann United States
Edel Healy Ireland
Shengli Yin China
Janice M. Kraniak United States
G Prinò Italy
Neelam Tejpal United States
Eva Brčáková
Citations per year, relative to Eva Brčáková Eva Brčáková (= 1×) peers Neelam Tejpal

Countries citing papers authored by Eva Brčáková

Since Specialization
Citations

This map shows the geographic impact of Eva Brčáková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Brčáková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Brčáková more than expected).

Fields of papers citing papers by Eva Brčáková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Brčáková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Brčáková. The network helps show where Eva Brčáková may publish in the future.

Co-authorship network of co-authors of Eva Brčáková

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Brčáková. A scholar is included among the top collaborators of Eva Brčáková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Brčáková. Eva Brčáková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rathouska, Jana, et al.. (2011). Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. Pharmacological Research. 64(1). 53–59. 17 indexed citations
2.
Brčáková, Eva, Petra Hirsova, Luděk Šišpera, et al.. (2011). Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis. Journal of Gastroenterology and Hepatology. 26(10). 1544–1551. 16 indexed citations
3.
Brčáková, Eva, Petra Hirsova, Jolana Cermanová, et al.. (2011). Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats. Life Sciences. 89(19-20). 717–724. 10 indexed citations
4.
Štěrba, Martin, Olga Popelová, Juraj Lenčo, et al.. (2011). Proteomic insights into chronic anthracycline cardiotoxicity. Journal of Molecular and Cellular Cardiology. 50(5). 849–862. 57 indexed citations
5.
Rathouska, Jana, et al.. (2011). Activation of TGF-β Receptors and Smad Proteins by Atorvastatin is Related to Reduced Atherogenesis in ApoE/LDLR Double Knockout Mice. Journal of Atherosclerosis and Thrombosis. 19(2). 115–126. 12 indexed citations
6.
Brůčková, Lenka, Tomáš Soukup, Benjamín Víšek, et al.. (2011). Proliferative potential and phenotypic analysis of long-term cultivated human granulosa cells initiated by addition of follicular fluid. Journal of Assisted Reproduction and Genetics. 28(10). 939–950. 19 indexed citations
7.
Rathouska, Jana, et al.. (2011). Cholesterol Effects on Endoglin and Its Downstream Pathways in ApoE/LDLR Double Knockout Mice. Circulation Journal. 75(7). 1747–1755. 21 indexed citations
8.
Mokrý, Jaroslav, Tomáš Soukup, Stanislav Mičuda, et al.. (2010). Telomere Attrition Occurs during Ex Vivo Expansion of Human Dental Pulp Stem Cells. SHILAP Revista de lepidopterología. 2010. 1–11. 37 indexed citations
9.
Nachtigal, Petr, et al.. (2009). Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice. Journal of Atherosclerosis and Thrombosis. 16(3). 265–274. 12 indexed citations
10.
Fuksa, Leoš, Eva Brčáková, Petra Hirsova, et al.. (2009). Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats. Toxicology. 267(1-3). 165–171. 24 indexed citations
11.
Soukup, Tomáš, M Hroch, Leoš Fuksa, et al.. (2009). Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase. International Orthopaedics. 34(1). 137–142. 14 indexed citations
12.
Cermanová, Jolana, Leoš Fuksa, Eva Brčáková, et al.. (2009). Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats. Pharmacological Research. 61(2). 129–135. 9 indexed citations
13.
Brčáková, Eva, Leoš Fuksa, Jolana Cermanová, et al.. (2009). Alteration of Methotrexate Biliary and Renal Elimination during Extrahepatic and Intrahepatic Cholestasis in Rats. Biological and Pharmaceutical Bulletin. 32(12). 1978–1985. 27 indexed citations
14.
Fuksa, Leoš, Eva Brčáková, Jolana Cermanová, et al.. (2008). Amiodarone modulates pharmacokinetics of low‐dose methotrexate in rats. Biopharmaceutics & Drug Disposition. 29(5). 289–299. 8 indexed citations
15.
16.
Tomšík, Pavel, Luděk Šišpera, Martina Řezáčová, et al.. (2008). Increased melibiose/rhamnose ratio in bile of rats with acute cholestasis. Journal of Gastroenterology and Hepatology. 23(12). 1934–1940. 6 indexed citations
17.
Mičuda, Stanislav, Eva Brčáková, Leoš Fuksa, et al.. (2008). P-glycoprotein function and expression during obstructive cholestasis in rats. European Journal of Gastroenterology & Hepatology. 20(5). 404–412. 10 indexed citations
18.
Mičuda, Stanislav, Leoš Fuksa, Eva Brčáková, et al.. (2007). Zonation of multidrug resistance‐associated protein 2 in rat liver after induction with dexamethasone. Journal of Gastroenterology and Hepatology. 23(7pt2). e225–30. 13 indexed citations
19.
Mičuda, Stanislav, Leoš Fuksa, Jan Österreicher, et al.. (2007). MORPHOLOGICAL AND FUNCTIONAL CHANGES IN P‐GLYCOPROTEIN DURING DEXAMETHASONE‐INDUCED HEPATOMEGALY. Clinical and Experimental Pharmacology and Physiology. 34(4). 296–303. 20 indexed citations
20.
Brčáková, Eva, et al.. (1996). [Successful surgical management of cardiovascular thrombosis and aortic coarctation, caused by protein C deficiency, in a newborn infant].. PubMed. 137(5). 251–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelam Tejpal Breakdown of academic impact, for papers by A. Kivitz Breakdown of academic impact, for papers by Weinan Du Breakdown of academic impact, for papers by Roberta Sarmiento Breakdown of academic impact, for papers by Gary L. Engelmann Breakdown of academic impact, for papers by Edel Healy Breakdown of academic impact, for papers by Shengli Yin Breakdown of academic impact, for papers by Janice M. Kraniak Breakdown of academic impact, for papers by G Prinò
Rankless by CCL
2026